作者:Shawn D. Erickson、Bruce Banner、Steven Berthel、Karin Conde-Knape、Fiorenza Falcioni、Irina Hakimi、Bernard Hennessy、Robert F. Kester、Kyungjin Kim、Chun Ma、Warren McComas、Francis Mennona、Steven Mischke、Lucy Orzechowski、Yimin Qian、Hamid Salari、John Tengi、Kshitij Thakkar、Rebecca Taub、Jefferson W. Tilley、Hong Wang
DOI:10.1016/j.bmcl.2008.01.010
日期:2008.2
This paper describes the lead optimization of a new series of potent, selective, orally bioavailable, brain-penetrant MCH-1 receptor antagonists. A major focus of the work was to achieve a selectivity pro. le appropriate for in vivo efficacy studies and safety. (c) 2008 Elsevier Ltd. All rights reserved.